| [1] |
Apisarnthanarax S, Tepper JE. Crossroads in the combined-modality management of gastroesophageal junction carcinomas[J]. Gastrointest Cancer Res，2008，2(5)：235-243.
|
| [2] |
Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction[J]. Ann Surg Oncol，2010，17(7)：1721-1724.
|
| [3] |
Wang K, Yang CQ, Duan LP, et al. Changing pattern of adenocarcinoma of the esophagogastric junction in recent 10 years: experience at a large tertiary medical center in China[J]. Tumori，2012，98(5)：568-574.
|
| [4] |
Huang Q. Carcinoma of the gastroesophageal junction in Chinese patients[J]. World J Gastroenterol，2012，18(48)：7134-7140.
|
| [5] |
Suh YS, Han DS, Kong SH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification[J]. Ann Surg，2012，255(5)：908-915.
|
| [6] |
Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan[J]. J Gastroenterol Hepatol，2008，23(11)：1662-1665.
|
| [7] |
Zhang H, Wang W, Cheng Y, et al. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China[J]. World J Surg Oncol，2013，11：155.
|
| [8] |
Hansen S, Vollset S E, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status[J]. Gut，2007，56(7)：918-925.
|
| [9] |
Hasegawa S, Yoshikawa T. Adenocarcinoma of the esophagogastric junction: incidence, characteristics, and treatment strategies[J]. Gastric Cancer，2010，13(2)：63-73.
|
| [10] |
Reynolds JV, Ravi N, Muldoon C, et al. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction[J]. World J Surg，2010，34(12)：2821-2829.
|
| [11] |
Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan[J]. Ann Surg Oncol，2012，19(2)：677-683.
|
| [12] |
Hasegawa S, Yoshikawa T, Aoyama T, et al. Esophagus or stomach? The seventh TNM classification for Siewert type Ⅱ/Ⅲ junctional adenocarcinoma[J]. Ann Surg Oncol，2013，20(3)：773-779.
|
| [13] |
Huang Q, Shi J, Feng A, et al. Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System[J]. Mod Pathol，2011，24(1)：138-146.
|
| [14] |
Gertler R, Stein H J, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer？[J] Am J Surg Pathol，2011，35(10)：1512-1522.
|
| [15] |
傅世杰，方文涛，茅腾，等．食管胃交界部腺癌与胸下段食管鳞癌外科治疗结果的比较分析[J]．中华胃肠外科杂志，2012，15(9)：893-896.
|
| [16] |
Hosokawa Y, Kinoshita T, Konishi M, et al. Recurrence patterns of esophagogastric junction adenocarcinoma according to Siewert’s classification after radical resection[J]. Anticancer Res，2014，34(8)：4391-4397.
|
| [17] |
Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification[J]. J Surg Oncol，2005，90(3)：139-146, 146.
|
| [18] |
Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients[J]. Surg Oncol Clin N Am，2006，15(4)：751-764.
|
| [19] |
Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial[J]. Ann Surg，2007，246(6)：992-1000, 1000-1001.
|
| [20] |
Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus[J]. N Engl J Med，2002，347(21)：1662-1669.
|
| [21] |
Peyre CG, Hagen JA, Demeester SR, et al. The number of lymph nodes removed predicts survival in esopha-geal cancer: an international study on the impact of extent of surgical resection[J]. Ann Surg，2008，248(4)：549-556.
|
| [22] |
陈克能．食管胃交界部腺癌新分期的解读及综合治疗新模式[J]．中华胃肠外科杂志，2010，13(9)：640-641.
|
| [23] |
Schiesser M, Schneider PM. Surgical strategies for adenocarcinoma of the esophagogastric junction[J]. Recent Results Cancer Res，2010，182：93-106.
|
| [24] |
肖文光，马可，彭林，等．食管胃交界部腺癌淋巴结转移特点及手术方式选择[J]．中华胃肠外科杂志，2012，15(9)：897-900.
|
| [25] |
Chen XZ, Zhang WH, Hu JK. Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophago-gastric junction[J]. Chin J Cancer Res，2014，26(3)：237-242.
|
| [26] |
Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial[J]. Lancet Oncol，2006，7(8)：644-651.
|
| [27] |
张晖，王圣应，彭德峰，等．胃食管连接部腺癌淋巴结转移规律[J]．中华胸心血管外科杂志，2012，28(1)：13-15.
|
| [28] |
Goto H, Tokunaga M, Miki Y, et al. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type Ⅱ and Siewert type Ⅲ patients[J]. Gastric Cancer，2014. [Epub ahead of print]
|
| [29] |
de Manzoni G, Morgagni P, Roviello F, et al. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study[J]. Gastric Cancer，1998，1(2)：146-151.
|
| [30] |
刘英俊，韩广森，王刚成．近端胃切除与全胃切除对SiewertⅡ～Ⅲ型食管胃结合部癌疗效比较的Meta分析[J]．中华胃肠外科杂志，2014，4(17)：373-377.
|
| [31] |
Takiguchi N, Takahashi M, Ikeda M, et al. Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by Postgastrectomy Syndrome Assessment Scale (PGSAS-45): a nationwide multi-institutional study[J]. Gastric Cancer, 2015, 18(2): 407-416.
|
| [32] |
Matsuda T, Takeuchi H, Tsuwano S, et al. Sentinel node mapping in adenocarcinoma of the esophagogastric junction[J]. World J Surg，2014，38(9)：2337-2344.
|